Details of the Drug | DrugMAP

General Information of Drug (ID: DMXQEAA)

Drug Name

IGF-MTX

Indication

Disease Entry	ICD 11	Status	REF
Chronic myelogenous leukaemia	2A20.0	Phase 1/2	[1]
Myelodysplastic syndrome	2A37	Phase 1/2	[1]
Solid tumour/cancer	2A00-2F9Z	Phase 1	[2]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D0P3ZF

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT02045368) Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R. U.S. National Institutes of Health.